Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle

Human Gene Therapy

Volumn 18, Issue 3, 2007, Pages 257-268

  Vigen, Karl K ^a,f   Hegge, Julia O ^b   Zhang, Guofeng ^c   Mukherjee, Rajat ^a   Braun, Serge ^d,e   Grist, Thomas M ^a   Wolff, Jon A ^b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Mirus Bio Corporation   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d TRANSGENE S A   (France)

^e Association Francaise Contre les Myopathies   (France)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; GADODIAMIDE; LUCIFERASE; NAKED DNA; PLASMID DNA;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; DRUG DISTRIBUTION; GENE EXPRESSION; HYDRODYNAMICS; LEG MUSCLE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; REPORTER GENE; RHESUS MONKEY; THREE DIMENSIONAL IMAGING;

ANIMALS; DNA; INJECTIONS, INTRAVENOUS; LUCIFERASES; MACACA MULATTA; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; PLASMIDS; TRANSDUCTION, GENETIC;

MACACA MULATTA; PRIMATES;

EID: 34247235162     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.115     Document Type: Article

References (39)

1. ABABNEH, Z., BELOEIL, H., BERDE, C.B., GAMBAROTA, G., MAIER, S.E., and MULKERN, R.V. (2005). Biexponential parameterization of diffusion and T2 relaxation decay curves in a rat muscle edema model: Decay curve components and water components. Magn. Reson. Med. 54, 524-531.
2. AMTHOR, H., EGELHOF, T., McKINNELL, I., LADD, M.E., JANSSEN, I., WEBER, J., SINN, H., SCHRENK, H.H., FORSTING, M., VOIT, T., and STRAUB, V. (2004). Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI. Neuromuscul. Disord. 14, 791-796.
3. BELL, J.D., and TAYLOR-ROBINSON, S.D. (2000). Assessing gene expression in vivo: Magnetic resonance imaging and spectroscopy. Gene Ther. 7, 1259-1264.
4. CHOI, V.W., McCARTY, D.M., and SAMULSKI, R.J. (2005). AAV hybrid serotypes: Improved vectors for gene delivery. Curr. Gene Ther. 5, 299-310.
5. COLE, M.A., RAFAEL, J.A., TAYLOR, D.J., LODI, R., DAVIES, K.E., and STYLES, P. (2002). A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. Neuromuscul. Disord. 12, 247-257.
6. DANIALOU, G., COMTOIS, A.S., MATECKI, S., NALBANTOGLU, J., KARPATI, G., GILBERT, R., GEOFFROY, P., GILLIGAN, S., TANGUAY, J.F., and PETROF, B.J. (2005). Optimization of regional intraarterial naked DNA-mediated transgene delivery to skeletal muscles in a large animal model. Mol. Ther. 11, 257-266.
7. DE MARCO, G., BOGDANOV, A., MARECOS, E., MOORE, A., SIMONOVA, M., and WEISSLEDER, R. (1998). MR imaging of gene delivery to the central nervous system with an artificial vector. Radiology 208, 65-71.
8. FLEISS, J.L. (2003). Statistical Methods for Rates and Proportions. (Wiley-Interscience, Hoboken, NJ).
9. GAMBAROTA, G., CAIRNS, B.E., BERDE, C.B., and MULKERN, R.V. (2001). Osmotic effects on the T2 relaxation decay of in vivo muscle. Magn. Reson. Med. 46, 592-599.
10. GENOVE, G., DEMARCO, U., XU, H., GOINS, W.F., and AHRENS, E.T. (2005). A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 11, 450-454.
11. 31P NMR study. Neuromuscul. Disord. 8, 371-379.
12. HAGSTROM, J.E., HEGGE, J., ZHANG, G., NOBLE, M., BUDKER, V., LEWIS, D.L., HERWEIJER, H., and WOLFF, J.A. (2004). A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol. Ther. 10, 386-398.
13. HANY, T.F., CARROLL, T.J., OMARY, R.A., ESPARZA-COSS, E., KOROSEC, F.R., MISTRETTA, C.A., and GRIST, T.M. (2001). Aorta and runoff vessels: Single-injection MR angiography with automated table movement compared with multi-injection time-resolved MR angiography - initial results. Radiology 221, 266-272.
14. HERWEIJER, H., and WOLFF, J. (2003). Progress and prospects: Naked DNA gene transfer and therapy. Gene Ther. 10, 453-458.
15. HUANG, Y., MAJUMDAR, S., GENANT, H.K., CHAN, W.P., SHARMA, K.R., YU, P., MYNHIER, M., and MILLER, R.G. (1994). Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J. Magn. Reson. Imaging 4, 59-64.
16. JIA, Z., and DANKO, I. (2005). Long-term correction of hyperbilirubinemia in the Gunn rat by repeated intravenous delivery of naked Plasmid DNA into muscle. Mol.-Ther. 12, 860-866.
17. KAYYEM, J.F., KUMAR, R.M., FRASER, S.E., and MEADE, T.J. (1995). Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem. Biol. 2, 615-620.
18. KOROSEC, F.R., FRAYNE, R., GRIST, T.M., and MISTRETTA, C.A. (1996). Time-resolved contrast-enhanced 3D MR angiography. Magn. Reson. Med. 36, 345-351.
19. LEROY-WILLIG, A., FROMES, Y., PATURNEAU-JOUAS, M., and CARLIER, P. (2003). Assessing gene and cell therapies applied in striated skeletal and cardiac muscle: Is there a role for nuclear magnetic resonance? Neuromuscul. Disord. 13, 397-407.
20. LEROY-WILLIG, A., BUREAU, M.F., SCHERMAN, D., and CARLIER, P.G. (2005). In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle. Gene Ther. 12, 1434-1443.
21. LIANG, K.W., NISHIKAWA, M., LIU, F., SUN, B., YE, Q., and HUANG, L. (2004). Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther. 11, 901-908.
22. LOUIE, A.Y., HUBER, M.M., AHRENS, E.T., ROTHBACHER, U., MOATS, R., JACOBS, R.E., FRASER, S.E., and MEADE, T.J. (2000). In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18, 321-325.
23. MARSHALL, D.J., and LEIDEN, J.M. (1998). Recent advances in skeletal-muscle-based gene therapy. Curr. Opin. Genet. Dev. 8, 360-365.
24. PATURNEAU-JOUAS, M., PARZY, E., VIDAL, G., CARLIER, P.G., WARY, C., VILQUIN, J.T., DE KERVILER, E., SCHWARTZ, K., and LEROY-WILLIG, A. (2003). Electrotransfer at MR imaging: Tool for optimization of gene transfer protocols - feasibility study in mice. Radiology 228, 768-775.
25. PRINCE, M.R., GRIST, T.M., and DEBATION, J.F. (2003). 3D Contrast MR Angiography. (Springer-Verlag, Berlin).
26. REEDER, S.B., PINEDA, A.R., WEN, Z., SHIMAKAWA, A., YU, H., BRITTAIN, J.H., GOLD, G.E., BEAULIEU, C.H., and PELC, N.J. (2005). Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): Application with fast spin-echo imaging. Magn. Reson. Med. 54, 636-644.
27. ROMERO, N.B., BRAUN, S., BENVENISTE, O., LETURCQ, F., HOGREL, J.Y., MORRIS, G.E., BAROIS, A., EYMARD, B., PAYAN, C., ORTEGA, V., BOCH, A.L., LEJEAN, L., THIOUDELLET, C., MOUROT, B., ESCOT, C., CHOQUEL, A., RECAN, D., KAPLAN, J.C., DICKSON, G., KLATZMANN, D., MOLINIER-FRENCKEL, V., GUILLET, J.G., SQUIBAN, P., HERSON, S., and FARDEAU, M. (2004). Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophy. Hum. Gene Ther. 15, 1065-1076.
28. SCHREIBER, A., SMITH, W.L., IONASESCU, V., ZELLWEGER, H., FRANKEN, E.A., DUNN, V., and EHRHARDT, J. (1987). Magnetic resonance imaging of children with Duchenne muscular dystrophy. Pediatr. Radiol. 17, 495-497.
29. SLATTUM, P.S., LOOMIS, A.G., MACHNIK, K.J., WATT, M.A., DUZESKI, J.L., BUDKER, V.G., WOLFF, J.A., and HAGSTROM, J.E. (2003). Efficient in vitro and in vivo expression of covalently modified plasmid DNA. Mol. Ther. 8, 255-263.
30. STRAUB, V., DONAHUE, K.M., ALLAMAND, V., DAVISSON, R.L., KIM, Y.R., and CAMPBELL, K.P. (2000). Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy. Magn. Reson. Med. 44, 655-659.
31. SU, L.T., GOPAL, K., WANG, Z., YIN, X., NELSON, A., KOZYAK, B.W., BURKMAN, J.M., MITCHELL, M.A., LOW, D.W., BRIDGES, C.R., and STEDMAN, H.H. (2005). Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector. Circulation 112, 1780-1788.
32. TOUMI, H., HEGGE, J., SUBBOTIN, V., NOBLE, M., HERWEIJER, H., BEST, T.M., and HAGSTROM, J.E. (2006). Rapid intravascular injection into limb skeletal muscle: A damage assessment study. Mol. Ther. 13, 229-236.
33. WALTER, G., BARTON, E.R., and SWEENEY, H.L. (2000). Noninvasive measurement of gene expression in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 97, 5151-5155.
34. WALTER, G., CORDIER, L., BLOY, D., and SWEENEY, H.L. (2005). Noninvasive monitoring of gene correction in dystrophic muscle. Magn. Reson. Med. 54, 1369-1376.
35. WEISSLEDER, R., MOORE, A., MAHMOOD, U., BHORADE, R., BENVENISTE, H., CHIOCCA, E.A., and BASILION, J.P. (2000). In vivo magnetic resonance imaging of transgene expression. Nat. Med. 6, 351-355.
36. WELLS, D.J. (2004). Opening the floodgates: Clinically applicable hydrodynamic delivery of plasmid DNA to skeletal muscle. Mol. Ther. 10, 207-208.
37. YANG, X., ATALAR, E., LI, D., SERFATY, J.-M., WANG, D., KUMAR, A., and CHENG, L. (2001). Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 104, 1588-1590.
38. ZHANG, G., GAO, X., SONG, Y.K., VOLLMER, R., STOLZ, D.B., GASIOROWSKI, J.Z., DEAN, D.A., and LIU, D. (2004a). Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther. 11, 675-682.
39. ZHANG, G., LUDTKE, J.J., THIOUDELLET, C., KLEINPETER, P., ANTONIOU, M., HERWEIJER, H., BRAUN, S., and WOLFF, J.A. (2004b). Intraarterial delivery of naked plasmid DNA expressing full-length mouse dystrophin in the mdx mouse model of Duchenne muscular dystrophy. Hum. Gene Ther. 15, 770-782.